INSEAD Day 4 - 728x90

Samsung biggest chip investor

The tech giant invested nearly $59.2bn in 2025.

flynas to set up new hub

Five destinations in first phase of operations.

AD Ports Group acquires CLI

CLI is Brazilian agri-bulk terminal operator.

$1.59bn Makkah project awarded

A consortium will develop two districts in the Holy City.

2PointZero posts profit surge

Growth driven by merger consolidation.

Vaccine patents accord possible in weeks, says WTO

WTO leader Ngozi Okonjo-Iweala and French minister for foreign trade Franck Riester participated in a press conference in Paris.
  • The vaccine accord will pe possible after the EU-African Union summit on February 17-18 in Brussels
  • Access to vaccine can be improved by lifting as far as possible restrictions to their distribution, says French minister

An accord between rich nations and developing countries on intellectual property waivers for Covid-19-vaccines could be just weeks away, the head of the World Trade Organization said on Friday.

Developing countries that are lagging behind in vaccinating their populations have been pushing for waivers on the patents, or intellectual property rights, on Covid-19 vaccines as they say this would help spur local production.

That has pitted them against a group of mostly developed countries, including prominently EU nations, which believe that would discourage innovation and that other steps can be taken to boost access to vaccines.

“We hope that within the next few weeks we can have a breakthrough” on what has been a bone of contention for months, WTO leader Ngozi Okonjo-Iweala told a press conference.

“We believe there could be a sensible landing zone, a sensible compromise solution that would allow developing countries more access to technology transfer and IP whilst protecting innovation and research, not discouraging it,” she added.

While a deal could be reached soon, it may not happen before the EU-African Union summit on February 17-18 in Brussels, said Okonjo-Iweala.

Addressing the same conference in Paris, French minister for foreign trade Franck Riester, said “what is important is access to vaccines.”

This can be improved by lifting as far as possible restrictions to their distribution, he said.